2 Comments

Astaxanthin is associated with the regulation of redox balance and multiple biological mechanisms, inflammation, cell death and lipid metabolism in humans, thus exerting benefits for skin condition, eye health, cardiovascular system, function neurological, exercise performance, and immune response. Astaxanthin is the best antioxidant among carotenoids and one of the most important components in the treatment of NAFLD. The use of astaxanthin, a xanthophyll carotenoid, as a dietary supplement to treat chronic metabolic diseases is becoming increasingly evident. According to increasing evidence, astaxanthin may prevent or even reverse NAFLD by reducing oxidative stress, inflammation, insulin resistance, lipid metabolism, and fibrosis. Furthermore, preclinical trials predict its potential effects, such as regulation of intestinal flora and antidiabetic activity. Astaxanthin provides antioxidant and anti-inflammatory protection with health, cardiovascular and visual benefits, stabilization of blood sugar levels, strengthening of the immune system, reduction of inflammation and associated diseases, and helps fight cancer, absorbent UVB rays and reduces DNA damage, protecting against burns. Astaxanthin is anti-cancer.

Astaxanthin increases its elasticity, reduces wrinkles and improves its moisture level. Unlike topical sunscreens, astaxanthin does not block UV rays, so it does not prevent UVB rays from being converted to vitamin D in your skin, this protects your skin from damage. Helps eliminate intracellular reactive oxygen species and reduce apoptosis. The progression of burn wounds by reducing oxidative stress-induced inflammation and mitochondria-related apoptosis.

In addition to being effective in combating COVID-19 and other respiratory diseases, astaxanthin has also been shown to provide health benefits, protecting against radiation and promoting skin, eye, brain and heart health. Several studies have shown the impact of astaxanthin on a wide range of diseases, particularly brain disorders (such as Alzheimer's disease, Parkinson's, depression, stroke and autism). Astaxanthin has been observed to slow brain aging by increasing levels of brain-derived neurotrophic factor (BDNF) in the brain, attenuating oxidative damage to lipids, proteins and DNA, and protecting mitochondrial functions. Emerging data now suggest that ASX may modulate the proteins Nrf2, FOXO3, Sirt1 and Klotho that are linked to longevity. Together, these mechanisms provide support for the role of astaxanthin as a potential geroneutroprotective.

Astaxanthin improves osteoblast differentiation, osteocyte number and/or differentiation, inhibits osteoclast differentiation, markers of cartilage degradation, and increases bone mineral density and expression of osteogenic markers, while reducing bone loss.

https://www.mdpi.com/1660-3397/21/10/514 (2023).------

https://www.mdpi.com/2076-3921/12/7/1480 (2023).------

https://www.tandfonline.com/doi/abs/10.1080/10408398.2021.1983766 (2023).-----

https://www.tandfonline.com/doi/abs/10.1080/10408398.2023.2232866 (2023).-----

https://www.mdpi.com/2076-3921/12/7/1480 (2023).--

https://www.mdpi.com/2076-3921/12/8/1552 (2023).--

https://www.mdpi.com/1660-3397/21/3/176 (2023).--

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333078/ (2023).---

https://www.mdpi.com/2072-6643/16/6/826 (2024).--

https://brieflands.com/articles/semj-141316 (2024).--

https://www.intechopen.com/online-first/89393 (2024).--

Expand full comment